Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Moleculin Biotech, Inc.MBRX · Entity 7886 | Chief Science Officer | August 03, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Moleculin Biotech, Inc.
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 174,086 |
Reported balance
After 2026-08-03 transaction · row 1
1 source rowRow 1 · 2026-08-03 · Purchase · Acquired 173,333 · Balance 174,086 F1: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. |
| Series I WarrantsSEC Table II · derivative / convertible security · Expires 2026-08-03 | Direct | 539,595 |
Reported balance
After 2026-08-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-03 · Purchase · Acquired 519,999 · Balance 539,595 F1: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | PurchaseSeries I Warrants · Derivative | 519,999 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025927 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,595 Underlying: Common Stock · 519,999 shares Expires 2026-08-03 F1 · derivative.exercise_price: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · price: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. F1 · balance_after: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:15 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | PurchaseCommon Stock | 173,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-025927 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,086 F1 · price: On August 3, 2026, The reporting person acquired 173,333 shares of common stock and Series I warrants to purchase 519,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 71 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · derivative · entry 6 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,596 Underlying: Common Stock · 50 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 283 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 283 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 21 | $3.12 | $65.52 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 4 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 22, 2026 Filed Jun 25, 2026 01:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 71 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 44 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · derivative · entry 5 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,667 Underlying: Common Stock · 44 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 173 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 173 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 13 | $2.88 | $37.44 |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 703 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2026 Filed Jun 25, 2026 01:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 44 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-26-021612 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:08 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantPerformance Based Restricted Stock Units · Derivative | 200,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-035186 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 495,508 Underlying: Common Stock · 200,000 shares Expires 2035-11-12 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 21:08 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 200,000 | Not disclosed Strike: $0.49 | Not disclosed |
DisclosureSEC source: 0001437749-25-035186 · rdgdoc.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · CSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,508 Underlying: Common Stock · 200,000 shares Expires 2035-11-12 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:25 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 8,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033684 · rdgdoc.xml · derivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,508 Underlying: Common Stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date F3 · derivative.expiration_date: On November 4, 2024, the reporting person was granted 35,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:25 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 2,131 | $0.50 | $1,059.11 |
DisclosureSEC source: 0001437749-25-033684 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,771 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| November 04, 2025 Filed Nov 7, 2025 01:25 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-033684 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 22, 2025 Filed Jun 23, 2025 20:34 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 1,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-021049 · rdgdoc.xml · derivative · entry 6 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,258 Underlying: Common Stock · 1,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 22, 2025 Filed Jun 23, 2025 20:34 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 430 | $0.27 | $114.81 |
DisclosureSEC source: 0001437749-25-021049 · rdgdoc.xml · nonDerivative · entry 4 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,152 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 22, 2025 Filed Jun 23, 2025 20:34 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 1,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-021049 · rdgdoc.xml · nonDerivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 20:34 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-021049 · rdgdoc.xml · derivative · entry 5 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,024 Underlying: Common Stock · 1,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 20:34 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 263 | $0.27 | $70.22 |
DisclosureSEC source: 0001437749-25-021049 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,816 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2025 Filed Jun 23, 2025 20:34 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 1,078 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-021049 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| November 04, 2024 Filed Nov 7, 2024 01:03 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantRestricted Stock Units · Derivative | 35,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-033705 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,358 Underlying: Common Stock · 35,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. F4 · derivative.expiration_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| November 04, 2024 Filed Nov 7, 2024 01:03 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 40,000 | Not disclosed Strike: $2.45 | Not disclosed |
DisclosureSEC source: 0001437749-24-033705 · rdgdoc.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,358 Underlying: Common Stock · 40,000 shares Expires 2034-11-04 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| October 25, 2024 Filed Nov 7, 2024 01:03 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantPerformance Based Restricted Stock Units · Derivative | 5,744 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-033705 · rdgdoc.xml · derivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,102 Underlying: Common Stock · 5,744 shares Expires 2033-12-29 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F5 · derivative.exercise_date: On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date. Read SEC document |
| June 22, 2024 Filed Jun 25, 2024 22:02 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 1,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-021199 · rdgdoc.xml · derivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,358 Underlying: Common Stock · 1,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 22, 2024 Filed Jun 25, 2024 22:02 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 524 | $3.74 | $1,959.76 |
DisclosureSEC source: 0001437749-24-021199 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,001 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 22, 2024 Filed Jun 25, 2024 22:02 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 1,766 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-021199 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-020997 · rdgdoc.xml · derivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,124 Underlying: Common Stock · 1,078 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 320 | $3.78 | $1,209.60 |
DisclosureSEC source: 0001437749-24-020997 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,759 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2024 Filed Jun 21, 2024 21:01 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 1,078 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-24-020997 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 22:19 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantRestricted Stock Units · Derivative | 105,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-018528 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437,948 Underlying: Common Stock · 105,938 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. F4 · derivative.expiration_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 22, 2023 Filed Jun 26, 2023 22:19 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.60 | Not disclosed |
DisclosureSEC source: 0001437749-23-018528 · rdgdoc.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,010 Underlying: Common Stock · 100,000 shares Expires 2033-06-22 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 23:03 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionRestricted Stock Units · Derivative | 16,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-018142 · rdgdoc.xml · derivative · entry 3 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,010 Underlying: Common Stock · 16,167 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 20, 2022, the reporting person was granted 64,667 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 20, 2022, the reporting person was granted 64,667 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 23:03 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Tax withholdingCommon Stock | 4,267 | $0.57 | $2,432.19 |
DisclosureSEC source: 0001437749-23-018142 · rdgdoc.xml · nonDerivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,006 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 23:03 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | Exercise / conversionCommon Stock | 16,167 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-23-018142 · rdgdoc.xml · nonDerivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,273 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| June 20, 2022 Filed Jun 22, 2022 23:05 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantRestricted Stock Units · Derivative | 64,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-22-015665 · rdgdoc.xml · derivative · entry 2 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,177 Underlying: Common stock · 64,667 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one shares of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. F4 · derivative.expiration_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 20, 2022 Filed Jun 22, 2022 23:05 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 65,000 | Not disclosed Strike: $1.49 | Not disclosed |
DisclosureSEC source: 0001437749-22-015665 · rdgdoc.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,510 Underlying: Common stock · 65,000 shares Expires 2032-06-20 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 16, 2021 Filed Jun 21, 2021 20:20 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 62,676 | Not disclosed Strike: $3.73 | Not disclosed |
DisclosureSEC source: 0001437749-21-015272 · rdgdoc.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,510 Underlying: Common Stock · 62,676 shares Expires 2031-06-16 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four equal annual installments, beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:13 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001659617-20-000171 · wf-form4_159415638537678.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-02 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:06 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000102 · wf-form4_156322120093753.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 100,000 shares Expires 2029-07-11 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 21:25 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033608 · tv496092_4.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common stock · 75,000 shares Expires 2028-06-06 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:04 UTC | Moleculin Biotech, Inc. MBRX · Entity 7886 | GrantStock option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $2.49 | Not disclosed |
DisclosureSEC source: 0001144204-17-051549 · v476494_4.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common stock · 60,000 shares Expires 2027-10-03 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.